News
Investment
Lifestyle
Videos
Search for:
Search
More
Contact
Features
News
Home
Biotech
Investment
Diagnostics
Agetech
Supplements
Innovation
AI/Digital
Economy
Investment
TruDiagnostic and NADMED partner on new NAD blood diagnostic
Investment
Longevity investment bulletin: Celmatix, BlueRock, TruDiagnostic and more
Investment
New data suggest investigational osteoarthritis drug may have promising senotherapeutic effect
AKL’s investigational oral osteoarthritis drug APPA may have a dual effect on senescence with potential in other diseases of aging.
Investment
Retro: A longevity biotech triple-threat?
Investment
Cyclarity: When bad guy cells have a change of heart
Investment
Stressed tissue and cellular burn-out? Enter the Mitochondrial Cycle
Investment
Cambrian Bio reveals new pipeline company with focus on AMPK activation
Investment
Longevity investment bulletin: Remedium Bio, GenSight Biologics, SomaLogic and more
Investment
First longevity clinical study design fetches FDA approval
Investment
Longevity investment bulletin: ChromaDex, Nightingale Health, Capsida and more
Investment
OpenAI CEO invested $180 million in longevity company Retro Bio
Investment
Meet the Founder: Yuri Deigin
Investment
MitoRx announces Scientific Advisory Board as its ASA enters final few weeks.
Investment
Plant-derived osteoarthritis drug ready for further Phase 2 trials
Investment
Longevity investment bulletin: Assured Allies, Fountain Life, Form Bio and more
Investment
Longevity company Biophysical Therapeutics emerges from stealth
Investment
Longevity investment bulletin: Longeveron, EVERMIND, Longevity Labs and more
Investment
How the longevity industry can deliver lives that are healthier – physically and mentally
Investment
Leonhardt Ventures and Lionheart Health file patent for bioelectric control of antiaging protein expression
Investment
Longevity investment bulletin: Five Alarm Bio, Capsida, MyMD and more
Investment
Causeway Therapeutics secures £8.75 million for Phase 2 trial of tendinopathy therapy
Investment
Longevity investment bulletin: Impact funds, Lineage Cell Therapeutics and Maximon
Investment
Longevity investment bulletin: Athersys, Maze, TreeFrog and more
Investment
Longevity investment bulletin: Cerevance, Frequency, Heartseed, Life Biosciences and more
Investment
Longevity investment bulletin: Insilico Medicine, Biophytis, Synartro and more
Investment
Making a noise about the silent killer
Investment
Cambrian BioPharma unveils new pipeline company
Investment
Biosplice announces data from osteoarthritis clinical trial – and the initiation of new phase 3 trial
Investment
Occuity look to pet longevity, targeting diabetes management in pets
Investment
Fountain Life announces $15 million investment
Investment
Sound opportunity: Hearing Diagnostics £1.1m funding augurs market breakthrough
Investment
Constructively disruptive – tackling atherosclerosis through disease reversal
Investment
Load More